FDA Inspection 1063664 — Vitalant
The FDA completed an inspection of Vitalant on July 27, 2018 in Bismarck, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 27, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bismarck, ND (United States)